Advancing precision medicine in esophageal squamous cell carcinoma using patient-derived organoids
Abstract Background Patient-derived organoids (PDOs) represent a promising approach for replicating the characteristics of original tumors and facilitating drug testing for personalized treatments across diverse cancer types. However, clinical evidence regarding their application to esophageal cance...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2024-12-01
|
| Rangatū: | Journal of Translational Medicine |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s12967-024-05967-1 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|